Research on enhancer reprogramming is revealing its critical roles in cancer, with studies exploring various aspects of the relationship between enhancers and cancer. Different therapeutic strategies are being investigated, including targeting transcription factors, super-enhancers, and other mechanisms. The field appears to be actively pursuing multiple avenues of research, with potential applications in various types of cancer.